TrialContemporary clinical trials2024

D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years.

Anna Turkova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.